AGM/EGMApr 28, 2026, 04:48 PM
PTGX 2026 Annual Meeting Set for June 17; Key Votes
AI Summary
Protagonist Therapeutics, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 17, 2026. Stockholders will vote on the election of two Class I director nominees, the non-binding advisory approval of executive compensation, the ratification of Ernst & Young LLP as the independent auditor for 2026, and the adoption of the 2026 Equity Incentive Plan. The record date for voting is April 22, 2026.
Key Highlights
- Annual Meeting scheduled for June 17, 2026, at 10:00 a.m. Pacific Time.
- Stockholders to elect two Class I director nominees until the 2029 Annual Meeting.
- Advisory vote on named executive officers' compensation.
- Ratification of Ernst & Young LLP as independent auditor for 2026.
- Approval of the Company's 2026 Equity Incentive Plan.
- Record date for voting is April 22, 2026.
- Board recommends "FOR" all proposals.
Price Impact
More from PTGX